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INTRODUCTION
Angiomyolipoma (AML) is a rare tumor in the
liver composed of varying mixtures of smooth mus-
cle, fat cells, and abnormal, thick-walled blood ves-
sels. Depending upon the dominant cell type, AML
can be subcategorized into epithelioid, spindle, and
intermediate forms (1). In 2000, epithelioid AML
(Epi-AML) was first described in the liver2. Re-
cently, several case reports of hepatic Epi-AML have
been described or reviewed in the literature (2-5).
Differential diagnosis of Epi-AML from hepatocellu-
lar carcinoma (HCC) and the metastatic sarcomatoid
variant of renal cell carcinoma are considered to be
difficult.
Liver tumors with arterioportal venous shunting
have generally been recognized to be malignant.
However, several authors have argued that arte-
rioportal venous shunting is not always a sign of ma-
lignancy (6-9).
We herein present a case of hepatic Epi-AML
with significant arterioportal venous shunting that
could barely be differentiated from HCC and suc-
cessfully treated with minimally invasive laparo-
scopic hepatectomy.
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CASE REPORT
A 46 year-old man without symptoms had a hy-
poechoic mass in the left lateral section. Under the
diagnosis of HCC, based on the findings of an en-
hanced computed tomography (CT) scan, he was
referred to our department for surgical treatment.
Laboratory tests revealed a leukocyte count of
5800 /mm3, 16.4 g/dL hemoglobin, a platelet count
of 26.6104/mm3, 4.5 g/dL albumin, 0.9 mg/dL to-
tal bilirubin, 0.2 mg/dL direct bilirubin, 38 IU/L se-
rum alanine transaminase, and a prothrombin time
of 10.4 s. The patient was negative for hepatitis B
surface antigen, hepatitis B surface antibody, hepa-
titis B e antigen, hepatitis B e antibody, and hepatitis
B core antibody, hepatitis B virus DNA, hepatitis
C antibody and hepatitis C virus RNA. The indocy-
anine green dye retention rate after 15 minutes was
10.9 % (normal range10 %). All serum tumor mark-
ers of α -fetoprotein (AFP), AFP-L3 and des-γ - car-
boxy prothrombin (DCP) were within normal limits.
Dynamic multi-detector computed tomography
(MDCT) showed a hypervascular mass, measuring
27 mm in diameter, in the arterial phase (Fig. 1A).
In the portal phase, the tumor had almost washed
out the contrast agent, but a weak contrast-enhanc-
ing effect had been sustained due to arterioportal
venous shunting (Fig. 1B), and almost showed
isodensity with the liver tissue in the delayed phase
(Fig. 1C). T1-weighted magnetic resonance im-
aging (MRI) revealed low intensity (Fig. 2A) and
T2-weighted MRI showed high intensity (Fig. 2B).
Gd ethoxybenzyl diethylenetriamine pentaacetic acid
(Gd-EOB-DTPA)-enhanced MRI in the hepatocyte
phase revealed low-intensity areas in the tumor 20
min after Gd-EOB-DTPA administration (Fig. 2C).
Figure 1 : Dynamic multi -detector computed tomography (MDCT).
1-A : Arterial phase showed a hypervascular mass in segment 2.
1-B : Portal phase showed it had almost washed out the contrast agent but a small contrast -enhancing effect had been sustained due
to arterioportal venous shunting.
1-C : Delayed phase almost showed isodensity with the liver tissue.
Figure 2 :Magnetic resonance imaging (MRI).
2 -A : T1-weighted MRI revealed the tumor was detected with low intensity area.
2 -B : T2-weighted MRI with high intensity area.
3 -C : Gd ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA)-enhanced MRI in the hepatocyte phase, 20 min after
Gd-EOB-DTPA administration, revealed low-intensity areas in the tumor.
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We could not exclude the possibility of HCC with
arterioportal venous shunting, and performed laparo-
scopic left lateral sectionectomy.
The resected specimen appeared to be a tuberous
tumor, measuring some 2522 mm in diameter, on
the cutting surface, and there were no macroscopic
evidence to suggest the presence of arterioportal
venous shunting (Fig. 3A). In our histopathological
findings, the hematoxylin-eosin (HE) stain revealed
many cells with acidophilic cytoplasm and a lower
nuclear-cytoplasmic ratio in the tumor tissues (Fig.
3B). Furthermore, immunohistochemical analysis
revealed a high expression of melanoma-associated
antigen (HMB45) (Fig. 4A), partial expression of α
smooth muscle actin (α -SMA) (Fig. 4B) and almost
no expression of MIB-1 (Fig. 4C). Following these
results, the final pathological diagnosis was deter-
mined to be Epi-AML.
Figure 3 :Macroscopic and histopathological findings.
3-A : Resected specimen appeared to be a tuberous tumor, measuring some 2522 mm in diameter, on the cutting surface.
3-B : Hematoxylin-eosin (HE) staining revealed there were many cells with acidophilic cytoplasm and a lower nuclear-cytoplasmic
ratio in the tumor area.
Figure 4 : Immunohistochemical analysis.
4 -A : High expression of melanoma-associated antigen (HMB45).
4-B : Partial expression of α smooth muscle actin (α -SMA).
4-C : Almost no expression of Mindbomb E3 ubiquitin protein ligase 1 (MIB-1).
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DISCUSSION
AML is a rare tumor most commonly found in the
kidneys, followed by the liver. Besides these organs,
it has also been identified in the uterus, retroperi-
toneum, mediastinum, renal capsule, nasopharynx,
penis, vagina, colon, skin, parotid gland, lung, and
spleen (3, 10). A case of hepatic AML was first re-
ported in 1976 (11). By 1999, 110 cases of hepatic
AML had been published in the literature (1), while
a rare variant, Epi-AML, was first described in 2000
(2). Considering from previous reports, hyper vas-
cularity with central punctiform or filiform vessels is
suggested to be a characteristic radiographic feature
for hepatic Epi-AML (12, 13), however, there were
no such findings in the present case. Histologically,
Epi-AML is reported to be strongly positive for
HMB45, which is the most sensitive immunohisto-
chemical marker for AML, and weakly to moder-
ately positive for α -SMA or desmin (2, 4, 13).
Arterioportal venous shunting is considered to be
one of the signs of a malignant liver tumor, and the
incidence of arterioportal venous shunting was re-
ported to be 20-30% in HCC (14). We have previ-
ously reported that hepatic resection for heman-
giomas with arterioportal venous shunting might be
recommended due to the high risk of rupture and
the possible progression of portal hypertension (15).
The route of arterioportal shunting is considered
either transsinusoidal or transvasal (7). Transsinu-
soidal route occurs in cases of cirrhosis or the Budd-
Chiari syndrome and results in retrograde hepato-
fugal flow in portal branches. On the other hand, in
transvasal route, portal flow often remains hepa-
topetal. The transvasal route occurs in cases of
HCC, metastases, shock, hepatic arterial obstruc-
tion, and many other conditions. To the best of our
knowledge, there have been no reports of Epi-AML
with arterioportal venous shunting so far and it is
difficult to assume the relation between its tumor
growth and arterioportal venous shunting.
Typical AMLs are regarded as universally be-
nign tumors and often grow slowly ; however, Epi-
AMLs are regarded as tumors of uncertain malig-
nant potential. Indeed, rare cases of Epi-AML with
tumor recurrence, and vascular invasion have re-
cently been reported (16, 17). Surgical resection
should thus be considered for all symptomatic pa-
tients. Conservative management with close follow-
up is suggested in asymptomatic patients with tu-
mors with a small mass (5 cm) that are diagnosed
through fine-needle aspiration biopsy (18).
Since hepatic Epi-AML with arterioportal venous
shunting is barely differentiated from HCC and po-
tentially malignant, minimally invasive hepatectomy
may be recommended.
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